Levin Capital Strategies’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
LP
Levin Capital Strategies's AGN Position: Q1 2019 in Review
Levin Capital Strategies sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 2,453 shares — an estimated $328K sold.
Levin Capital Strategies first reported a position in AGN in Q2 2014 and held it in 19 quarters. The position peaked at $162M in Q1 2015. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.
- Levin Capital Strategies reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
- Levin Capital Strategies sold 2,453 Allergan plc shares in Q1 2019, an estimated $328K.
- Levin Capital Strategies first reported a position in Allergan plc in Q2 2014 and held it in 19 quarters.
- Levin Capital Strategies's Allergan plc position peaked at $162M in Q1 2015.
- 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.
Based on Levin Capital Strategies's 13F filing for Q1 2019, filed 13 May 2019.